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ABSTRACT
The diverse localization of transcripts in cells
suggests that there are many specific RNA–protein
interactions that have yet to be identified. Progress
has been limited, however, by the lack of a robust
method to detect and isolate the RNA-binding
proteins. Here we describe the use of an RNA
aptamer, scaffolded to a tRNA, to create an affinity
matrix that efficiently pulls down transcript-specific
RNA-binding proteins from cell lysates. The addition
of the tRNA scaffold to a Streptavidin aptamer
(tRSA) increased binding efficiency by  10-fold.
The tRSA system with an attached G-quartet
sequence also could efficiently and specifically
capture endogenous Fragile X Mental Retardation
Protein (FMRP), which recognizes this RNA
sequence. An alternative method, using biotinylated
RNA, captured FMRP less efficiently than did our
tRSA method. Finally we demonstrate the identifica-
tion of novel RNA-binding proteins that interact
with intron2 or 30-UTR of the polarity protein
Crumbs3 transcript. Proteins captured by these
RNA sequences attached to the tRNA scaffold
were identified by mass spectrometry. GFP-tagged
versions of these proteins also showed specific
interaction with either the Crb3 intron2 or 30-UTR.
Our tRSA technique should find wide application in
mapping the RNA–protein interactome.
INTRODUCTION
High throughput proteomics and protein–protein inter-
action screens have enabled rapid progress to be made
in mapping the protein ‘interactome’. The RNA–protein
interactome is likely to be much larger and more complex
than this, given the huge numbers of transcripts identiﬁed
by recent global analyses (1–3), and the diversity of RNA
localization and function in cells (4). Yet progress in the
identiﬁcation of transcript-speciﬁc RNA-binding proteins
(RBPs) has been surprisingly slow. In general, it has been
much easier to ﬁnd RNAs that bind to speciﬁc proteins,
rather than vice versa. RNA is unstable and ﬂexible, which
causes problems not only during isolation of binding
proteins but also for designing functional tags.
Prokipcak et al. (5) were able to purify a protein binding
to c-myc mRNA by classical puriﬁcation and RNA
afﬁnity chromatography (5). Ross et al. (6) successfully
used synthetic oligoribonuceotides with a 30-biotinylated
end spacer for afﬁnity puriﬁcation of proteins that bind to
the zipcode in the 30-UTR of actin mRNA (6). RNA
afﬁnity columns have also been used to purify a few
other proteins including a complementation factor
involved in Apobec-1 dependent RNA editing, in which
the target RNA was transcribed in vitro then biotinylated
and attached to Streptavidin beads (7). However, synthetic
oligoribonucleotides are expensive, their afﬁnity for target
proteins is often low, and chemical labeling is likely to
alter the secondary structure of the RNAs.
A promising alternative to chemical labeling is the use
of RNA aptamers. Aptamers bind to speciﬁc molecules
that can be used both to track RNA localization in
living cells and in afﬁnity chromatographic methods to
isolate RBPs (8–10). Some RNA tags, including MS2,
PP7 and lambda N22, are naturally occurring sequences,
while others, such as Streptavidin and Sephadex aptamers,
have been found by screening synthetic libraries (11). An
afﬁnity selection approach with a tobramycin aptamer was
used by Hartmuth et al. (16) for the isolation of the
prespliceosomal complex (12). However, these strategies
have all required multiple puriﬁcation steps and
specialized reagents such as recombinant proteins or
afﬁnity matrices, which might explain why they have not
been widely adopted.
Transfer RNA scaffolding technology was developed
for the efﬁcient expression and puriﬁcation of RNAs in
Escherichia coli (13). In the presence of Mg
2+, tRNAs fold
into stable clover-leaf structures that are resistant to un-
folding and can protect RNA fusions from degradation
(14). Ponchon and Dardel (13) demonstrated that intact
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from bacterial lysates, and that they were correctly
folded. Moreover, endogenous L20 protein could be
co-precipitated, though with low efﬁciency, from bacterial
lysate using a tRNA-scaffolded sephadex aptamer-
23SrRNA fusion. We reasoned, therefore, that tRNA
might provide a useful scaffold for the afﬁnity puriﬁcation
of transcript-speciﬁc RBPs.
We now describe an approach that uses available ma-
terials and provides for ﬂexible, robust and efﬁcient puri-
ﬁcation of transcript-speciﬁc RBPs.
MATERIALS AND METHODS
Plasmid construction and antibodies
Streptavidin aptamer (SA) tags were generated by primer
annealing and PCR, using the following sequences:
tRNA scaffolded SA tag: 50-CAATTGAAAAAAAAAAAAA
GCCCGGATAGCTCAGTCGGTAGAGCAGCGGCCTC
GACCAGAATCATGCAAGTGCGTAAGATAGTCGCG
GGTCGAGGCCGCGTCCAGGGTTCAAGTCCCTGTTC
GGGCGCCACTGCAGAAAAAAAAAAAAGAATTC
(Figure 1a)
1  SA tag: CAATTGGTCGACCGACCAGAATCATGCA
AGTGCGTAAGATAGTCGCGGGCCGGGGGCGTATT
ATGTGCGTCTACATGAATTC
DNA fragments were digested with MunI and EcoRI, and
ligated into the EcoRI site of pcDNA3 (Invitrogen). Since
MunI and EcoR1 sites are cohesive, only the 30-EcoR1 site
is retained after ligation. The 6  stretavidin aptamer (6 
SA) was generated by repeatedly cloning the 1  SA
fragment into this surviving EcoRI site. These plasmids
were designated pcDNA3-tRNA scaffolded SA (tRSA),
pcDNA3-1  SA and pcDNA3-6  SA, respectively.
To generate expression plasmid encoding MS2-GFP
without nuclear localization signal (NLS), pcNMS2-
GFP-NLS was digested with HindIII and XhoI, and the
MS2-GFP fragment was cloned into corresponding sites
of pcDNA3.
18  MS2 binding sequences (MBS) was ampliﬁed by
PCR from b-globin-24bs/- plasmid with following primers,
MBS forward: 50-GAGCTGTACAAGGGCGAATTCGCTT
GGTCTAGCTC,
MBS reverse: 50-GCCCTCGAGCGATTCTAGACAGCAG
The 18  MBSs PCR fragment was digested with EcoRI
and XhoI, and cloned into corresponding sites of
pcDNA3-tRSA, pcDNA3-1  SA and pcDNA3-6  SA,
30 to the tags.
The G quartet fragment with EcoRI and XhoI sites was
generated with the following primers;
G quartet forward: 50-AATTCGGCTGCGGTGTGGAAGGA
GTGGCTGGGTTGCGCAGCTC
G quartet reverse: 50-TCGAGAGCTGCGCAACCCAGCCA
CTCCTTCCACACCGCAGCCG
The primers were annealed and cloned into corresponding
sites of pcDNA3-tRSA.
Human Crumbs3 intron2 and 30-UTR fragments were
ampliﬁed using the CalTech human BAC clone (Clone#:
CTD-2396E7-BHS1214, Open Biosystems) as PCR
template. Primers were as follows,
Intron2 forward: 50-GCCGAATTCGTAGGTACCAGCTG
AGAGCGC,
Intron2 reverse: 50-GCCCTCGAGTGGAGGGTGAAGG
CAGAGAATAAC,
30-UTR forward: 50-GCCGAATTCTAGGTCCCCTCTCCT
GCATCT,
30-UTR reverse: 50-ATACTCGAGACATCTCACTACTA
ATTTTATATAAATATA.
PCR products were all ligated into pcDNA3-tRSA cut
with EcoRI and XhoI. For the GFP-tagged RBP assay,
EGFP lacking a stop codon was ampliﬁed from
pEGFP-C1 (Clontech), and cloned between the BamHI
and EcoRI sites of pcDNA3, designated pcDNA-
nEGFP. ADAR1, GRSF1, hnRNP M and hnRNP F
genes were ampliﬁed from Caco-2 cell cDNA, and
Nucleolin was ampliﬁed from pRSET-Nucleolin
(Plasmid 13037, addgene) using the following primers.
hADAR1 forward Mun: 50-GGCCAATTGACCATGGCC
GAGATCAAGGAGAAAATC
T
hADAR1 reverse Xho: 50-GCCCTCGAGCTATACTGGG
CAGAGATAAAAGTTC
Nucleolin forward Eco: 50-GCCGAATTCACCATGGTGA
AGCTCGCGAAGGCAGGTA
Nucleolin reverse Xho: 50-GCCCTCGAGCTATTCAAAC
TTCGTCTTCTTTCC
GRSF1 Mun: 50-GGCCAATTGACCATGGCC
GGCACGCGCTGGGTACTCG
GRSF1 Xho: 50-GGCCTCGAGTTATTTTCCT
TTTGGACATGAATTC
hnRNPF forward Mun: 50-GCCCAATTGACCATGATGC
TGGGCCCTGAGGGAGGT
hnRNPF reverse Xho: 50-GCCCTCGAGCTAGTCATAG
CCACCCATGCTGTT
hnRNPMb. forward Mun: 50-GCCCAATTGACCATGGCG
GCAGGGGTCGAAGCGGC
hnRNPMb reverse Sal: 50-GCCGTCGACTTAAGCGTTT
CTATCAATTCGAAC
PCR products of all these genes were digested with EcoRI
or MunI and XhoI or SalI, and ligated into cut
pcDNA3-nEGFP cut with EcoRI and XhoI. Plasmids
were conﬁrmed by sequencing.
Anti-GFP (Ab13970, Abcam), anti-TLS/FUS
(ab23439, Abcam) or anti-Fragile X Mentor Retardation
Protein (FMRP) (MAB2160, Chemicon) were used for
western blot detection.
In vitro RNA synthesis
In vitro RNA synthesis using AmpliScribe
TM T7-Flash
TM
Transcription Kit or AmpliScribe
TM T7-Flash
TM Biotin-
RNA Transcription Kit (Epicentre Biotechnologies) were
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Template DNAs were prepared by PCR using T7 primer
and speciﬁc primers, and puriﬁed with QIAquick PCR
Puriﬁcation Kit (Qiagen). Synthesized RNAs were
analyzed qualitatively and quantitatively by electrophor-
esis and spectrometry, then stored at  80 C.
RNA pull-down assay
A schematic of the method for afﬁnity puriﬁcation of
RBPs is shown in Figure 1b. For the experiments
reported in Figures 2a and 3b, HEK293 cells were
plated on 10cm tissue culture dishes. About 20mg
MS2-GFP plasmid was transfected using Lipofectamine
2000, using the manufacturer’s protocol. Cells were main-
tained in DMEM with 10% FBS and penicillin–strepto-
mycin at 37 Ci n5 %C O 2. Two days post-transfection,
cells were harvested by adding 5ml lysis buffer (10mM
HEPES pH 7.0, 200mM NaCl, 1% Triton  -100,
10mM MgCl2, 1mM DTT and protease inhibitors).
Lysis buffer was prepared with 0.1% DEP-treated water.
Total cell lysates were lightly sonicated, and centrifuged
for 10min at 16000g,4  C. Supernatants were transferred
to new tubes and protein was quantiﬁed by measuring
absorbance at 280nm. Egg white avidin (EMD chemicals,
Cat#:189725, 10mg/mg protein) and Yeast RNA (Sigma,
Cat#R6750,  0.5mg/mg protein) were added to block en-
dogenous biotinylated proteins and non-speciﬁc RNPs,
and incubated on a rotation shaker at 4 C, for 20min.
After blocking, the lysates were again centrifuged for
10min at 16000g,4  C, to prepare the ﬁnal pre-cleared
lysates. Supernatants were transferred to new tubes with
200U/ml RNasin (Promega, cat#: N2115). In tandem
with lysate preparation, 10mg of synthetic RNAs were
denatured at 65 C for 5min then cooled to room tempera-
ture in the presence of 10mM HEPES and 10mM MgCl2.
RNAs were applied to 30ml streptavidin beads (Pierce,
Cat#:20349). Streptavidin beads were washed 2  with
lysis buffer before adding RNAs. The RNA tethering
reaction was done in 300ml lysis buffer including
200U/ml RNasin, by incubating on a rotating shaker at
4 C for 20min. Beads were then washed twice with fresh
lysis buffer, and precleared lysates were applied to the
RNA beads. After 1.5h incubation, beads were washed
 5 with fresh lysis buffer. Captured proteins were
analyzed by SDS–PAGE and immunoblotting.
In some experiments, 60ml RNA beads were prepared
by adding 30mg synthetic RNAs for each samples.
Subsequently, half were applied for RNA pull-down,
and half were treated with 200ml Trizol (Invitrogen) to
recover retained RNAs without adding protein samples.
About 7.5mg of each RNA was recovered and 1.5mgo f
these RNAs were analyzed by formaldehyde agarose gel
electrophoresis.
For LC/MS analysis, Caco-2 cells (24 15cm dish, ap-
proximately 10
8 cells) were maintained in DMEM
Figure 1. tRSA construction and procedure. (a) Schematic of the tRNA-scaffolded streptavidin aptamer employed for this assay. Bait RNAs are
attached to the 30-end of a transfer RNA-SA fusion. (b) Schematic of the method. Precleared cell lysate and RNA beads are prepared in parallel.
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at 37 Ci n5 %C O 2. Cells were harvested after the cells
reached conﬂuence by adding 10ml lysis buffer. After har-
vesting cells, the detergent concentration was corrected by
adding 10% Triton  -100. To prepare the RNA beads,
50mg of RNAs (tRSA, tRSA+intron 2 and tRSA+30-
UTR) were added on 100ml bed volume Streptavidin
beads. About 8mg protein was applied for each
pull-down. After precipitation, the ﬁnal sample volume
was adjusted to 100ml by adding sample buffer. Samples
(20ml) were analyzed by SDS–PAGE followed by silver
staining, and unique protein bands were cut for mass spec-
trometry analyses.
Mass spectrometry
Protein gel bands were excised and in-gel digested with
trypsin (0.6mg), and the tryptic peptides were subjected
to matrix-assisted laser desorption-ionization mass spec-
trometry (MALDI-MS) on an Applied Biosystems 4700
Proteomic Analyzer time of ﬂight (TOFTOF) mass
spectrometer. Positive mode time of ﬂight was used to
identify peptides, and individual peptides were sequenced
by MS/MS using collision-induced dissociation.
All sequence and peptide ﬁngerprint data was searched
using the NCBI database and Mascot search engine.
RESULTS
tRSA tag improves the efﬁciency of RNA pull-down assay
As a starting point we employed the S1 SA for RNA
afﬁnity capture of RNPs. We attached the SA via a
linker to the 50-side of the bait RNA (15). However, this
construct bound only weakly to the Streptavidin beads.
To improve the efﬁciency, we tested two strategies
(Figure 2a). First, we created tandemly repeated
aptamers (6 SA), which we reasoned would increase
both the afﬁnity and speciﬁcity for the afﬁnity matrix.
Second, because aptamers are likely to be ﬂexible and
may adopt structures that do not recognize their target,
we constructed tRNA-scaffolded aptamers.
To test the efﬁciency of these systems for the puriﬁca-
tion of RBPs, we employed the MS2 phage coat protein
and its cognate RNA binding sequence (MBS). The MBS
was attached to the 30-ends of the aptamer constructs (see
schematic in Figure 1a). Initially, chimeras were expressed
in HEK293 cells together with GFP-tagged MS2, and
Figure 2. The tRSA tag improves Streptavidin-binding efﬁciency, and can detect endogenous RBP. (a) RNA pull-down systems were tested using
MS2 protein as a positive control. RNAs were transcribed in vitro and attached to streptavidin beads. RNA tags included tRSA, 1  SA and 6  SA
aptamers, which were attached to 18  MBSs (MS2 binding sequences). Capture was performed with lysates of HEK 293 cells that expressed
MS2-GFP. About 500mg total protein were applied for each pull-down. Synthesized bait RNAs were quantiﬁed spectrometrically, and analyzed by
gel electrophoresis in agarose containing 6.7% formaldehyde. (b) tRSA afﬁnity tags can detect endogenously expressed protein. A single G quartet
was attached to the tRSA. Pull-down was from 2mg wild type HEK293 whole cell lysate protein. Proteins retained on the beads after washing were
analyzed by immunoblot with anti-FMRP or anti-TLS/FUS antibodies. Half the beads then were kept aside to quantify tethered RNAs. Retained
RNAs on the beads were quantiﬁed spectrometrically, and analyzed by gel electrophoresis in agarose containing 6.7% formaldehyde. (c) The tRSA
method is more efﬁcient than a biotinylated RNA pull-down. Pull-down was from 2mg wild-type HEK293 whole cell lysate protein. Proteins
retained on the beads after washing were analyzed by immunoblot with anti-FMRP RNA baits used in panels b and c were synthesized by in vitro
transcription.
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we were unable to capture any detectable GFP-MS2 under
these conditions (data not shown). Therefore, we ex-
pressed the RNA chimeras in vitro, and attached them
to beads prior to adding cell lysate (see schematic of
method in Figure 1b). Single SA-, 6  SA-, and
tRSA-tagged MBS were synthesized in vitro as bait
RNAs (Figure 2a). Surprisingly, tRSA-tagged MBS
captured the GFP-MS2 protein from cell lysates with
10-fold higher efﬁciency than did the 1  SA tag, while
the 6  SA tag showed much lower efﬁciency than the
single SA tag (Figure 2a). To evaluate how efﬁciently
various RNAs were tethered, we treated the beads with
Trizol to release the RNAs, and the extracts were analyzed
by formaldehyde gel electrophoresis. Single SA and 6  SA
tagged MBS RNAs were almost undetectable, whereas
tRSA tagged RNAs showed clear bands (Figure 2a). We
conclude that the tRNA scaffold signiﬁcantly improves
SA function. The failure of the 6  SA may be due to
interference of one aptamer sequence with another,
leading to misfolded structures that cannot recognize
Streptavidin.
The tRSA tag is applicable to detect endogenously
expressed RBP by RNA pull-down assay
To evaluate whether the tRSA system is applicable to the
detection of endogenously expressed RBPs, we chose
Fragile X Mental Retardation Protein (FMRP, also
called FMR1), which interacts with a speciﬁc sequence
motif, called the G quartet, through its RGG box. The
G quartet was ﬁrst identiﬁed as a FMRP binding RNA
element by an in vitro selection strategy, and is frequently
found in FMRP target mRNAs (16). We prepared
tRSA-tagged G quartet RNA in vitro, and performed
pull-down assays from HEK293 lysates. About 60 pmols
each of synthetic RNAs were added to 30ml bed volume
SA beads to prepare the RNA beads. Lysate containing
2mg protein was applied for each pull-down. Beads were
washed 5  with lysis buffer, and analyzed by
immunoblot. Notably, the G quartet afﬁnity tag speciﬁc-
ally captured endogenous FMRP, but did not bind to a
different RBP, TLS/FUS (Figure 2b). These data demon-
strate that the tRSA system can speciﬁcally capture en-
dogenous RBPs. We further tested the tRSA system by
comparison with a standard biotinylated-RNA pull-
down assay (Figure 2c). Biotinylated tRSA, and a G
quartet lacking the tRSA scaffold sequence were
synthesized, and pull-down assays were performed from
the same whole cell lysate as was used for the tRSA
pull-downs. The tRSA sequence itself did not bind to
FMRP with either method (Figure 2c). However, RNA
tethering efﬁciency and FMRP pull-down efﬁciency were
both higher with the tRSA-G quartet than with the
biotinylated G-quartet (Figure 2c). The afﬁnity of tRSA
tag to beads was reduced by biotinylation (Figure 2c),
possibly because biotinylation affects formation of sec-
ondary structures in RNAs. These data indicate that our
tRSA system is able to capture RBPs with higher efﬁ-
ciency than a traditional biotinylated RNA pull-down
method.
Identiﬁcation of novel transcript-speciﬁc RNP by tRSA
system
To test the ability of the tRSA system to identify novel,
transcript-speciﬁc RBPs, we focused on the Crumbs3
(Crb3) gene. The Drosophila genome contains a single
Crb gene that is essential for epithelial polarity, and its
mRNA localizes to the apical surface (4). The 30-UTR is
required for Crb mRNA localization, but the zipcode
within this region has not been mapped, and RBPs
required for transport and anchoring of the transcript
have not been identiﬁed (17).
We recently found that the mammalian Crb3 mRNA is
also apically localized in epithelial cells (H. Iioka and I.G.
Macara, unpublished data). To screen for RBPs that rec-
ognize speciﬁc elements within the Crb3 mRNA, we
created tRSA chimeras with the 192-nt 30-UTR and the
761-nt intron2 of the human Crb3 transcript. Empty tRSA
RNA was used as a negative control. Afﬁnity selection
was performed using cell lysate from human intestinal epi-
thelial Caco-2 cells. Lysate was pre-blocked with 10mg
white egg avidin/mg protein. RNA beads were prepared
by coupling 50mg of RNAs (tRSA, tRSA + intron2 or
tRSA+30-UTR) to 100ml streptavidin beads, and  8mg
of protein was applied for each pull-down.
Proteins retained on the beads were analyzed by silver
staining, and the patterns were strikingly different for the
Intron2 and 30-UTR RNA tags as compared with the
empty tRSA (Figure 3a). We identiﬁed the major bands
by LC/MS, and almost all were RBPs (Table 1).
Encouragingly, one of the bands speciﬁc to the
30-UTR-tRSA pull-down was Staufen1, which is known
as a regulator of mRNA localization and interacts with
the 30-UTRs of target mRNAs. In addition, hnRNPs and
GRSF1, which may be involved in pre-mRNA processing,
were speciﬁcally captured by Crb3 intron2 (Table 1).
To validate the speciﬁcities of these RBPs, we con-
structed N-terminally GFP-tagged versions and expressed
them transiently in HEK293 cells. Lysates from 10cm
dishes were divided between different RNA beads for
afﬁnity capture. Most of the GFP-proteins showed
speciﬁc interaction with either the intron2 or 30-UTR
RNA tags (Figure 3b).
DISCUSSION
RNA aptamers are potentially ideal RNA tags for the
analysis of RNP interactions. Yet in practice, aptamers
have not worked well to isolate RNPs from cell lysates,
especially for proteins that interact with mRNAs or
pre-mRNA complexes (11). RNA folding is a critical
factor not only for aptamer function but also for RNA–
protein interactions. However, there is no generalized
strategy to design bait RNAs that will fold correctly and
maintain a stable conformation. Here we have shown the
effectiveness of a scaffolding strategy to stabilize the
aptamer RNA conformation. Using this approach, we
successfully demonstrated the identiﬁcation of novel
RNA–RNP interactions using Crb3 mRNA. Strikingly,
different sets of proteins bound to the 30-UTR versus the
second intron of this transcript.
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interacted also with the tRSA negative control, even
though there was no detectable interaction with the
tRSA-Intron2. Such associations might arise if the
protein participates in translation regulation and
the translation complex interacts with the tRNA
segment of the tRSA tag. For this reason, we recommend
the use of another negative control rather than the empty
tRSA tag.
Our tRSA pull-down is simple and effective, special
reagents are not required, and it can be applied ﬂexibly
from small-scale functional analyses to high throughput
screens. These advantages should make the isolation of
RBPs almost as simple as protein immunoprecipitations.
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